Norepinephrine Bitartrate Solution
Product Images NDC 65219-140

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 65219-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Nor0p 0000 01)

FDA Label Image

Logo (Nor0p 0000 02)

FDA Label Image

Package Label – Principal Display Panel – Norepinephrine Shelf Carton (Nor0p 0000 03)

FDA Label Image

Package Label – Principal Display Panel – Norepinephrine Vial Label (Nor0p 0000 04)

Package Label – Principal Display Panel – Norepinephrine Vial Label (Nor0p 0000 04)
This text describes a medication in the form of an injection containing Norepinephrine. The medication is stored at room temperature and should be protected from light. The usual dosage is not specified. The medication should be diluted before use and is only for intravenous infusion. The injection comes in a 4 mL single-dose vial and contains sulfites. The unused portion should be discarded, and the medication is only available with a prescription. The manufacturer is Fresenius Kabi located in Lake Zurich, IL, and it was made in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.